{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T05:59:08Z","timestamp":1715752748536},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,6,2]],"date-time":"2009-06-02T00:00:00Z","timestamp":1243900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> We present a rare case of cerebral hemorrhage due to Epstein\u2013Barr virus (EBV)\u2010associated post\u2010transplant lymphoproliferative disorder (PTLD). A 58\u2010year\u2010old man with myelodysplastic syndrome received allogeneic hematopoietic stem cell transplantation from an unrelated donor after being conditioned with fludarabine, melphalan, and total body irradiation. Tacrolimus and methotrexate were given for graft\u2010versus\u2010host disease (GVHD) prophylaxis. On day 23, he developed acute GVHD, which was successfully treated with prednisolone (PSL). The tapering of PSL failed because of extensive chronic GVHD involving the liver and lungs, and mycophenolate mofetil was added on day 244. On day 340, the patient suddenly complained of severe headache. Computed tomography confirmed subcortical hemorrhage, and he died on day 348. The autopsy revealed atypical lymphocytes infiltrating the brain and meninges, which were positive for B\u2010cell\u2010associated antigens and EBV\u2010encoded RNA, and thus EBV\u2010associated PTLD was diagnosed.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2009.00409.x","type":"journal-article","created":{"date-parts":[[2009,6,3]],"date-time":"2009-06-03T01:19:17Z","timestamp":1243991957000},"page":"438-441","source":"Crossref","is-referenced-by-count":8,"title":["Primary central nervous system post\u2010transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation"],"prefix":"10.1111","volume":"11","author":[{"given":"Y.","family":"Aisa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10]]},"reference":[{"key":"e_1_2_4_2_2","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation","volume":"94","author":"Curtis RE","year":"1999","journal-title":"a multi-institutional study"},{"key":"e_1_2_4_3_2","first-page":"539","article-title":"Preemptive diagnosis and treatment of Epstein\u2013Barr virus\u2010associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant","volume":"37","author":"Weinstock DM","year":"2006","journal-title":"an approach in development"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-011791"},{"key":"e_1_2_4_5_2","first-page":"1059","article-title":"The role of HLA mismatch, splenectomy and recipient Epstein\u2013Barr virus seronegativity as risk factors in post\u2010transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Sundin M","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704089"},{"key":"e_1_2_4_7_2","first-page":"251","article-title":"B cell lymphoproliferative disorders following hematopoietic stem cell transplantation","volume":"23","author":"Gross TG","year":"1999","journal-title":"risk factors, treatment and outcome"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.9.3633.bloodjournal8793633"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909213211203"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05439.x"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190601059837"},{"key":"e_1_2_4_12_2","first-page":"222","article-title":"Lymphomas after solid organ transplantation","volume":"4","author":"Opelz G","year":"2004","journal-title":"a collaborative transplant study report"},{"key":"e_1_2_4_13_2","first-page":"956","article-title":"Chemotherapy for posttransplant lymphoproliferative disorder","volume":"37","author":"Buell JF","year":"2005","journal-title":"the Israel Penn International Transplant Tumor Registry experience"},{"key":"e_1_2_4_14_2","first-page":"775","article-title":"Analysis of factors that influence survival with post\u2010transplant lymphoproliferative disorder in renal transplant recipients","volume":"5","author":"Trofe J","year":"2005","journal-title":"the Israel Penn International Transplant Tumor Registry experience"},{"key":"e_1_2_4_15_2","first-page":"2735","article-title":"Post\u2010transplant lymphoproliferative disorders occurring after renal transplantation in adults","volume":"6","author":"Caillard S","year":"2006","journal-title":"report of 230 cases from the French Registry"},{"key":"e_1_2_4_16_2","first-page":"954","article-title":"Posttransplant lymphoproliferative disorder","volume":"37","author":"Buell JF","year":"2005","journal-title":"significance of central nervous system involvement"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2-4-229"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1309\/N82CTQ1J0XEVEFQB"},{"key":"e_1_2_4_19_2","first-page":"1695","article-title":"Pediatric central nervous system posttransplant lymphoproliferative disorder","volume":"26","author":"Brennan KC","year":"2005","journal-title":"Am J Neuroradiol"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500254208"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4287"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.12.4364"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704061"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000055132"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2009.00409.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2009.00409.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:31:44Z","timestamp":1696865504000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2009.00409.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1399-3062.2009.00409.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2009.00409.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}